LAMENESS IN GOATS IS A PAINFUL CONDITION WITH SERIOUS HEALTH AND WELFARE IMPLICATIONS. CURRENTLY, THERE ARE LIMITED DATA AVAILABLE REGARDING ANALGESIC DRUG THERAPY IN GOATS BECAUSE VALIDATED METHODS OF PAIN ASSESSMENT ARE NEEDED FOR US FDA TO APPROVE THESE MEDICATIONS. GOALS FOR THIS PROJECT ARE TO: DELIVER FACIAL GRIMACE AND PRESSURE MAT GAIT ANALYSIS METHODS TO OBJECTIVELY ASSESS LAMENESS PAIN IN GOATS; ENHANCE THE MANAGEMENT OF LAMENESS PAIN BY PROVIDING DOSE, ROUTE, DURATION, FREQUENCY AND WITHHOLD PERIOD RECOMMENDATIONS FOR PAIN RELIEVING DRUGS IN GOATS; AND ASSURE CONSUMER SAFETY BY CHARACTERIZING MILK AND EDIBLE TISSUE DEPLETION KINETICS TO BE USED TO ESTABLISH APPROPRIATE WITHHOLDING INTERVALS. KNOWLEDGE GAINED FROM THIS PROPOSAL WILL ADDRESS CURRENT ANIMAL WELFARE CONCERNS BY DELIVERING METHODS TO ASSESS ANIMALS FOR PAIN, FILL VOIDS IN THE LITERATURE REGARDING PHARMACOLOGIC INTERVENTIONS, AND CHARACTERIZE MILK AND EDIBLE TISSUE DEPLETION KINETICS FOLLOWING PHARMACOLOGIC INTERVENTIONS. THESE ACTIVITIES WILL MAINTAIN CONSUMER CONFIDENCE IN THE PRODUCTION PRACTICES OF MEAT AND DAIRY GOAT SYSTEMS.